Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure
- 19 November 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 32 (5) , 1194-1200
- https://doi.org/10.1016/s0735-1097(98)00392-1
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart FailureCirculation, 1996
- Role of oxidative stress in transition of hypertrophy to heart failureJournal of the American College of Cardiology, 1996
- Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.Journal of Clinical Investigation, 1995
- Solving the mystery of nitrate tolerance. A new scent on the trail?Circulation, 1993
- Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin.Circulation, 1991
- Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteineJournal of the American College of Cardiology, 1990
- Antianginal effects of intravenous nitroglycerin over 24 hours.Circulation, 1988
- Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart FailureNew England Journal of Medicine, 1987
- Tolerance to organic nitrates.Circulation, 1986
- Desensitization to nitroglycerin in vascular smooth muscle from rat and humanBiochemical Pharmacology, 1986